🇮🇳 → 🇨🇦 Canada Entry 2026 Embiotic Laboratories · North America
Embiotic Laboratories · Canadian Market Entry

India's trusted
pharmaceutical manufacturer, now serving Canada.

Over 35 years of pharmaceutical manufacturing excellence — Embiotic Laboratories enters the Canadian market exclusively through New Era Pharma, bringing WHO-GMP quality products to pharmacies, clinics, and hospitals across North America.

Explore Portfolio The Partnership
35+
Years Manufacturing
8
Therapeutic Categories
100+
Active Formulations
Embiotic
Embiotic Laboratories
WHO-GMP Pharmaceutical Manufacturer · India
🤝
Exclusive
Canadian
Channel
NEP
Canada
New Era Pharma
Exclusive Distributor · Barrie, Ontario · Health Canada GDP
Our Story

Built on three decades of pharmaceutical trust.

Founded in 1987–88 in Bengaluru, Karnataka, Embiotic Laboratories Private Limited has spent over three decades building deep expertise in pharmaceutical manufacturing — developing formulations across eight therapeutic categories and serving thousands of healthcare partners across India.

With two ultramodern manufacturing facilities — the original Kottigepalya plant on Magadi Road and our expanded Kumbalgodu facility on Mysore Road — Embiotic operates with WHO-GMP certification and an unwavering commitment to quality, safety, and patient outcomes.

In 2026, Embiotic takes its next defining step: entering the Canadian pharmaceutical market. Through an exclusive partnership with New Era Pharma — a Health Canada GDP-compliant distributor based in Barrie, Ontario — Embiotic products will reach Canadian pharmacies, clinics, and hospitals with the same rigour and integrity that defines our operations in India.

🇮🇳 India · 🇨🇦 Canada — One quality standard. Two continents.

🏥
Patient First
Every decision flows from one principle — the patient deserves the best, always.
🔬
Scientific Excellence
Rigorous research, ethical conduct, and data integrity at every stage.
💡
Breakthrough Innovation
Continuous discovery to develop formulations that address unmet medical needs.
⚖️
Integrity and Trust
Complete transparency, accountability, and ethical responsibility at every step.
Manufacturing Infrastructure

Two state-of-the-art manufacturing facilities in Bengaluru — Kottigepalya (Magadi Road) and Kumbalgodu (Mysore Road) — equipped with advanced R&D laboratories, a fully staffed Quality Assurance Centre (QAC), and dedicated marketing divisions. All production lines are WHO-GMP certified and continuously audited.

Our Journey

35 years. One purpose. A new frontier.

1987–88
Founded
Established in Bengaluru, Karnataka — a pharmaceutical company built on quality, science, and patient care.
1992
Operations Began
First manufacturing facility launched at Kottigepalya, Magadi Road — full production and market entry in India.
2005
Second Facility
Ultramodern second manufacturing plant opened at Kumbalgodu, Mysore Road — expanding capacity and therapeutic range significantly.
2015+
Scale and Growth
Expanded to 100+ formulations across 8 therapeutic categories. Served thousands of healthcare partners across India with consistent quality and reliability.
2026
Canada — The Next Chapter
Embiotic enters the Canadian pharmaceutical market exclusively through New Era Pharma — bringing WHO-GMP quality to pharmacies, clinics, and hospitals across Ontario and beyond.
35+
Years of Manufacturing Excellence
8
Therapeutic Categories
100+
Active Formulations
2
WHO-GMP Certified Facilities
Therapeutic Portfolio

Eight categories. Every essential.

Embiotic's Canadian portfolio covers the full spectrum of pharmaceutical needs — each formulation manufactured to WHO-GMP standards and positioned for Health Canada compliance review.

🦠
Category 01
Antibiotics
Broad and narrow-spectrum antibacterial formulations across tablets, suspensions, injections, and dry syrups.
Elpicef Ulticlav Elpiclar Erazith Twocef
🧫
Category 02
Antifungal / Antiparasitic
Targeted antifungal and antiparasitic treatments in topical and oral formulations.
Nuconazole Empen-F Synarin AF
🫀
Category 03
Antacids / Antiulcerants
Gastrointestinal care formulations for acid management and ulcer treatment across tablets, capsules, and suspensions.
Controsec Elcid Megagel Hytide LSRAB
💊
Category 04
Analgesic / Anti-Inflammatory
Pain management and anti-inflammatory therapies — tablets, injections, gels, and sustained-release formulations.
Oronac Dolide Celonac Elpicox Oromol
🤧
Category 05
Anticold / Antiallergics
Respiratory and allergy relief formulations covering tablets, syrups, nasal sprays, and drops for all age groups.
Allerhin Synarin Emflaz Tricold
🌀
Category 06
Anti-Nauseant
Anti-emetic and nausea management formulations for clinical and outpatient settings.
Emon Elpigest Dylock
⚗️
Category 07
Hormones
Hormonal formulations for endocrine management including corticosteroids and related therapeutics.
Emflaz 6mg Emflaz 12mg PM 75
🌿
Category 08
Nutritional Supplements
Vitamins, minerals, iron formulations, and multivitamin complexes across tablets, syrups, injections, and nano shots.
Haemiron Elivit-M Omnical-D3 Embiotic-D3 Neufer
The Exclusive Arrangement

One manufacturer. One channel. Zero compromise.

Embiotic's Canadian market entry is built on an exclusive distribution arrangement with New Era Pharma — the sole authorised channel for warehousing, marketing, and distributing Embiotic products across Canada. This means total brand control, consistent quality standards, and a unified market presence from day one.

01
Exclusive Warehousing
All Embiotic products imported into Canada are received, inspected, and stored exclusively through New Era Pharma's Health Canada GDP-compliant facility in Barrie, Ontario.
02
Exclusive Distribution
New Era Pharma is the sole distribution channel for Embiotic products in Canada — pharmacies, hospitals, and clinics access Embiotic only through this partnership. No parallel channels, no brand dilution.
03
Exclusive Marketing Platform
Market positioning, healthcare partner outreach, and brand representation in Canada are managed exclusively by New Era Pharma — ensuring Embiotic's identity reaches Canadian providers with consistency and clarity.
Quality and Compliance

Indian manufacturing rigour.
Canadian regulatory alignment.

WHO-GMP
WHO-GMP Certified Manufacturing
Both Embiotic manufacturing facilities operate under WHO Good Manufacturing Practice certification — the internationally recognised benchmark for pharmaceutical production quality and safety.
Health Canada GDP
Canadian Distribution Standards
New Era Pharma's Canadian operations are fully aligned with Health Canada's Good Distribution Practices — ensuring every Embiotic product handled in Canada meets federal regulatory requirements from receipt to delivery.
R&D + QAC
In-House Research and Quality Assurance
Embiotic's dedicated R&D and Quality Assurance Centre (QAC) oversees formulation development and product integrity at every stage — from raw material sourcing through to finished product release.
Batch Traceability
Full Forward and Backward Traceability
Every SKU, lot number, and delivery is fully documented and traceable — meeting Health Canada documentation requirements and providing Canadian partners with complete batch-level assurance.
Cold Chain
Temperature-Sensitive Handling
End-to-end cold chain monitoring for biologics, vaccines, and temperature-sensitive formulations — from Embiotic's facilities in India through to Canadian healthcare delivery points.
FIFO Protocol
Inventory Integrity
Strict First-In-First-Out inventory rotation with batch-level tracking and automated shortage monitoring — ensuring product freshness and supply continuity for every Canadian partner.
How We Enter Canada

End-to-end readiness. From day one.

01
Regulatory Pathway Planning
Product-by-product Health Canada submission strategy — DIN applications, TMA filings, and compliance roadmap developed in partnership with Canadian regulatory specialists.
02
Import and Customs Compliance
Full documentation packaging for pharmaceutical importation — including Certificates of Analysis, WHO-GMP certification, and customs classification for each product line.
03
Warehousing and GDP Setup
Embiotic products received at New Era Pharma's Barrie facility — climate-controlled, GDP-compliant storage with FIFO inventory control and batch-level tracking from first shipment.
04
Canadian Market Outreach
Structured outreach to independent pharmacies, hospital formulary committees, and clinic networks across Ontario — with a phased expansion plan across BC and Alberta.
05
Delivery, Support, and Growth
Tracked shipment, post-delivery documentation, and ongoing account management — building lasting Canadian healthcare partnerships that grow with Embiotic's portfolio.
What New Era Pharma Brings
  • Established Canadian pharmaceutical distribution infrastructure in Barrie, Ontario
  • Full Health Canada Good Distribution Practices compliance
  • Active relationships with independent pharmacies and walk-in clinic networks across Ontario
  • Cold chain and temperature-controlled warehousing capability
  • Regulatory documentation and import compliance expertise
  • Dedicated account management for each healthcare partner
  • Planned expansion coverage across Ontario, BC, and Alberta
  • Exclusive commitment — Embiotic is the sole manufacturing partner for this channel
Geographic Expansion Plan
🇨🇦 OntarioPhase 1 — Launch
🇨🇦 British ColumbiaPhase 2
🇨🇦 AlbertaPhase 2
🇺🇸 United StatesFuture
Get In Touch

Let's build this together.

Whether you are a Canadian pharmacy, hospital, clinic, or a prospective healthcare partner — reach out to discuss product availability, distribution arrangements, or to request our Embiotic Canada portfolio catalogue. We respond within one business day.

Phone
(705) 331-2951
Mon–Fri, 8:30 AM – 5:30 PM ET
Email
info@nep-canada.com
orders@nep-canada.com
Distribution HQ · Canada
2229 Lockhart Drive
Barrie, ON L4M 3B1, Canada
🇨🇦 Embiotic Canada Office — Coming Soon
As Canadian operations expand, a dedicated Embiotic Canada office and contact point will be established. Details will be confirmed as part of the market entry plan. For now, all Canadian enquiries are handled exclusively by New Era Pharma.